{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T15:00:17Z","timestamp":1786460417508,"version":"build-2736575974"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"abstract":"\n Objective:<\/jats:title>\n This scoping review describes the methodological rigor and reporting quality of clinical practice guidelines for adults hospitalized with bacterial pneumonia.<\/jats:p>\n <\/jats:sec>\n \n Introduction:<\/jats:title>\n Health care professionals rely on clinical practice guidelines as authoritative sources for evidence-based treatment recommendations. To increase awareness of the current state of guideline rigor and reporting quality, this scoping review focused on the management of bacterial pneumonia in hospitalized adults.<\/jats:p>\n <\/jats:sec>\n \n Eligibility criteria:<\/jats:title>\n This review included national and international clinical practice guidelines for the care of adult and older adult patients (18 years or older) who were male, female, or gender-diverse and hospitalized with bacterial pneumonia. Guidelines published between 2017 and 2022 for adult patients with multiple diagnoses\/comorbidities were included if the primary focus was management of bacterial pneumonia in the inpatient, hospital setting.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n \n A 3-step search was conducted following JBI methodology for scoping reviews. A total of 1533 records were identified: 1524 from 8 databases (ie, CINAHL [EBSCOhost], Cochrane Database of Systematic Reviews, Embase [Embase.com], Epistemonikos, Google Scholar,\n JBI Evidence Synthesis<\/jats:italic>\n , PubMed, Web of Science Core Collection), and 9 from other sources (professional organizations [n=6], citation searching [n=3]). Following deduplication, 1293 titles and abstracts were screened, and 1232 were excluded. One guideline from other sources (ie, citation searching) was excluded because it was out of print and unavailable. Full-text screening was completed on 69 guidelines to determine eligibility (databases [61], other sources [8]). Of these, 54 guidelines were excluded as duplicate records, ineligible populations, or ineligible concepts. The remaining 15 national and international guidelines were included.\n <\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n Fifteen guidelines were authored in 13 different countries (5 continents). All guidelines were endorsed by at least 1 professional organization, and 9 guidelines were endorsed by 2 or more organizations. Most guidelines were published in English, although German, Russian, and Spanish guidelines were also included. The results for the AGREE II Domain 3, Rigor of Development, showed a mean score of 56% (range 15% to 90%). The AGREE II scores showed significant variability within and across all domains, which affected results of overall assessment (6 guidelines were rated high quality, 7 were rated sufficient, 2 were rated low) and reviewers\u2019 recommendations on use (2 guidelines were recommended for use in current form, 11 with modifications prior to use, and 2 were not recommended for use in current form). The RIGHT Checklist showed that 64% of guidelines included information on evidence and 56% included clear treatment recommendations. The AGREE Reporting Checklist showed that 4 guidelines addressed 1 focal area (evidence selection [n=2], monitoring\/auditing criteria to measure application of guideline recommendations [n=1], updating the procedure [n=1]).<\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n Methodological rigor and reporting quality of guidelines cannot be presumed. This scoping review showed deficiencies in 13 of 15 guidelines. Significant areas of weakness were found in the areas of rigor of development, evidence information, stakeholder involvement, applicability, recommendation information, review and quality assurance information, funding and declaration of conflicts of interest, and updating the procedure. These results underscore the need for guideline developers to use standardized appraisal instruments during development and reporting. Developers should include detailed, final self-assessments alongside the published guidelines to enhance transparency, foster trust, and, ultimately, support the delivery of high-quality patient care. It is the responsibility of guideline authors, endorsing organizations, journal editors and publishers, and health care providers to assess these qualities prior to dissemination and use.<\/jats:p>\n <\/jats:sec>\n \n Review registration:<\/jats:title>\n OSF https:\/\/osf.io\/h896x\/<\/jats:p>\n <\/jats:sec>","DOI":"10.11124\/jbies-24-00565","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T07:00:07Z","timestamp":1759388407000},"page":"2206-2235","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Methodological rigor and reporting quality of clinical practice guidelines for adults hospitalized with bacterial pneumonia: a scoping review"],"prefix":"10.11124","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9493-6165","authenticated-orcid":false,"given":"Amy Hagedorn","family":"Wonder","sequence":"first","affiliation":[{"name":"Indiana University School of Nursing, Bloomington, IN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1694-3797","authenticated-orcid":false,"given":"Jan M.","family":"Nick","sequence":"additional","affiliation":[{"name":"School of Nursing, Loma Linda University, Loma Linda, CA, USA"},{"name":"JBI Center for Evidence Synthesis Loma Linda University Health, Loma Linda, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5448-9348","authenticated-orcid":false,"given":"Olayemi O.","family":"Adeoye","sequence":"additional","affiliation":[{"name":"JBI Center for Evidence Synthesis Loma Linda University Health, Loma Linda, CA, USA"},{"name":"School of Pharmacy, Loma Linda University, Loma Linda, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2598-2536","authenticated-orcid":false,"given":"Gurmeet","family":"Sehgal","sequence":"additional","affiliation":[{"name":"JBI Center for Evidence Synthesis Loma Linda University Health, Loma Linda, CA, USA"},{"name":"University Libraries, Loma Linda University, Loma Linda, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"issue":"6","key":"R3-20260406","doi-asserted-by":"crossref","first-page":"e0233457","DOI":"10.1371\/journal.pone.0233457","article-title":"Reasons for readmission after hospital discharge in patients with chronic diseases: information from an international dataset","volume":"15","author":"Brunner-La Rocca","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"R5-20260406","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cmi.2020.07.041","article-title":"Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study","volume":"27","author":"Garcia-Vidal","year":"2021","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"R6-20260406","doi-asserted-by":"crossref","first-page":"784130","DOI":"10.3389\/fcimb.2022.784130","article-title":"Secondary bacterial infection and clinical characteristics in patients with COVID-19 admitted to two intensive care units of an academic hospital in Iran during the first wave of the pandemic","volume":"12","author":"Pourajam","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"R7-20260406","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajem.2021.09.040","article-title":"Bacterial infections and death among patients with COVID-19 versus non COVID-19 patients with pneumonia","volume":"51","author":"Scott","year":"2022","journal-title":"Am J Emerg Med"},{"issue":"4-5","key":"R8-20260406","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.micinf.2020.05.007","article-title":"Clinical characteristics and co-infections of 354 hospitalized patients with COVID-19 in Wuhan China: a retrospective cohort study","volume":"22","author":"Lv","year":"2020","journal-title":"Microbes Infect"},{"issue":"8","key":"R9-20260406","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/resp.14311","article-title":"One-year follow-up CT findings in COVID-19 patients: a systematic review and meta-analysis","volume":"27","author":"Watanabe","year":"2022","journal-title":"Respirol"},{"key":"R12-20260406","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jclinepi.2020.07.018","article-title":"Guidelines in low and middle income countries paper 2: quality assessment of Chilean guidelines: need for improvement in rigor, applicability, updating, and patients\u2019 inclusion","volume":"127","author":"Loezar","year":"2020","journal-title":"J Clin Epidemiol"},{"key":"R13-20260406","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jclinepi.2020.06.036","article-title":"Guidelines in low and middle income countries paper 3: appraisal of Philippine clinical practice guidelines using Appraisal of Guidelines for Research and Evaluation II: improvement needed for rigor, applicability, and editorial independence","volume":"127","author":"Dans","year":"2020","journal-title":"J Clin Epidemiol"},{"key":"R14-20260406","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jclinepi.2021.06.025","article-title":"Quality of clinical practice guidelines in Japan remains low: a cross-sectional meta-epidemiological study","volume":"138","author":"Kataoka","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"R15-20260406","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jclinepi.2021.03.005","article-title":"The methodological quality is insufficient in clinical practice guidelines in the context of COVID-19 pandemic: systematic review","volume":"135","author":"Stamm","year":"2021","journal-title":"J Clin Epidemiol"},{"issue":"76","key":"R16-20260406","first-page":"1","article-title":"Characteristics and quality of clinical practice guidelines for depression in adults: a scoping review","volume":"19","author":"Zafra-Tanaka","year":"2019","journal-title":"BMC Psychiatry"},{"issue":"4","key":"R17-20260406","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s10567-019-00292-2","article-title":"A systematic review and evaluation of clinical practice guidelines for children and youth with disruptive behavior: rigor of development and recommendations for use","volume":"22","author":"Andrade","year":"2019","journal-title":"Clin Child Fam Psychol Rev"},{"issue":"223","key":"R18-20260406","first-page":"1","article-title":"Quality of pediatric clinical practice guidelines","volume":"21","author":"Liu","year":"2021","journal-title":"BMC Pediatr"},{"issue":"18","key":"R22-20260406","doi-asserted-by":"crossref","first-page":"E839","DOI":"10.1503\/cmaj.090449","article-title":"AGREE Next Steps Consortium. AGREE II: advancing guideline development, reporting and evaluation in healthcare","volume":"182","author":"Brouwers","year":"2010","journal-title":"CMAJ"},{"issue":"i1152","key":"R24-20260406","first-page":"1","article-title":"AGREE Next Steps Consortium. The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines","volume":"352","author":"Brouwers","year":"2016","journal-title":"BMJ"},{"issue":"2","key":"R25-20260406","doi-asserted-by":"crossref","first-page":"128","DOI":"10.7326\/M16-1565","article-title":"A reporting tool for practice guidelines in health care: the RIGHT statement","volume":"166","author":"Chen","year":"2017","journal-title":"Ann Intern Med"},{"issue":"1","key":"R26-20260406","first-page":"50","article-title":"Understanding GRADE: an introduction","volume":"6","author":"Goldet","year":"2013","journal-title":"JEBM"},{"issue":"7650","key":"R27-20260406","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"1","key":"R28-20260406","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.injury.2022.01.047","article-title":"Clinical practice guidelines: the good, the bad, and the ugly","volume":"54","author":"Guerra-Farfan","year":"2023","journal-title":"Injury"},{"issue":"3","key":"R29-20260406","doi-asserted-by":"crossref","first-page":"617","DOI":"10.11124\/JBIES-22-00212","article-title":"Methodological rigor and reporting quality of clinical practice guidelines for adults hospitalized with bacterial pneumonia: a scoping review protocol","volume":"21","author":"Wonder","year":"2023","journal-title":"JBI Evid Synth"},{"issue":"10","key":"R30-20260406","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.11124\/JBIES-20-00167","article-title":"Updated methodological guidance for the conduct\u00a0of scoping reviews","volume":"18","author":"Peters","year":"2020","journal-title":"JBI Evid Synth"},{"issue":"7","key":"R32-20260406","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"issue":"39","key":"R33-20260406","first-page":"1","article-title":"PRISMA-S: an extension to the PRISMA Statement for reporting literature searches in systematic reviews","volume":"10","author":"Rethlefsen","year":"2021","journal-title":"Syst Rev"},{"key":"R34-20260406","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"R35-20260406","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/XEB.0000000000000152","article-title":"The development of software to support multiple systematic review types: the Joanna Briggs Institute System for the Unified Management, Assessment and Review of Information (JBI SUMARI)","volume":"17","author":"Munn","year":"2019","journal-title":"Int J Evid Based Healthc"},{"issue":"S1","key":"R37-20260406","first-page":"1","article-title":"Community-acquired pneumonia. Regulations of the Spanish Society of Pneumonology and Thoracic Surgery (SEPAR). Update 2020","volume":"56","author":"Men\u00e9ndez","year":"2020","journal-title":"Archiv Bronconeumonol"},{"issue":"1","key":"R38-20260406","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.enfi.2022.05.005","article-title":"Update of the recommendations of the Zero Pneumonia project","volume":"33","author":"Arias-Rivera","year":"2022","journal-title":"Enferm Intensiv"},{"issue":"9","key":"R39-20260406","first-page":"665","article-title":"Management of adult patients with community-acquired pneumonia and prevention\u2013update 2021","volume":"75","author":"Ewig","year":"2021","journal-title":"Pneumol"},{"issue":"4","key":"R40-20260406","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/23744235.2017.1399316","article-title":"Management of community-acquired pneumonia in immunocompetent adults: updated Swedish guidelines 2017","volume":"50","author":"Athlin","year":"2018","journal-title":"Infect Dis"},{"issue":"1","key":"R41-20260406","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jmii.2018.11.004","article-title":"Infectious Diseases Society of Taiwan, Taiwan Society of Pulmonary and Critical Care Medicine, Medical Foundation in Memory of Dr. Deh-Lin-Cheng, Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases Research and Education, Cy Lee\u2019s Research Foundation for Pediatric Infectious Diseases and Vaccines, 4th Guidelines Recommendations for Evidence-based Antimicrobial agents use in Taiwan (GREAT) Working Group. Recommendations and guidelines for the treatment of pneumonia in Taiwan","volume":"52","author":"Chou","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"issue":"2","key":"R42-20260406","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3947\/ic.2018.50.2.160","article-title":"Guideline for antibiotic use in adults with community-acquired pneumonia","volume":"50","author":"Lee","year":"2018","journal-title":"Infect Chemother"},{"issue":"9","key":"R43-20260406","doi-asserted-by":"crossref","first-page":"e13545","DOI":"10.1111\/ctr.13545","article-title":"AST Infectious Diseases Community of Practice. Pneumonia in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Dulek","year":"2019","journal-title":"Clin Transplant"},{"key":"R44-20260406","doi-asserted-by":"crossref","first-page":"79","DOI":"10.21518\/2079-701X-2019-15-79-88","article-title":"Community-acquired pneumonia in hospitalized patients: clinical guidelines","volume":"15","author":"Zaytsev","year":"2019","journal-title":"Meditsinskiy Sovet"},{"issue":"2","key":"R46-20260406","first-page":"99","article-title":"Pneumonia associated with mechanical ventilation. Update and recommendations inter-Societies SADI-SAT, Argentine Society of Infectious Diseases \u2013 Argentine Society of Intensive Therapy","volume":"78","author":"Cornistein","year":"2018","journal-title":"Medicina (B Aires)"},{"issue":"1","key":"R47-20260406","first-page":"83","article-title":"Hospital-acquired pneumonia in ICU","volume":"37","author":"Leone","year":"2018","journal-title":"Anaesth Crit Care Pain Med"},{"issue":"3","key":"R48-20260406","first-page":"1700582","article-title":"International ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of hospital-acquired pneumonia (HAP)\/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS","volume":"50","author":"Torres","year":"2017","journal-title":"European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociaci\u00f3n Latinoamericana del T\u00f3rax (ALAT). Eur Respir J"},{"issue":"6","key":"R49-20260406","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.21037\/jtd.2019.06.09","article-title":"Chinese guidelines for the diagnosis and treatment of hospital-acquired pneumonia and ventilator-associated pneumonia in adults (2018 edition)","volume":"11","author":"Shi","year":"2019","journal-title":"J Thorac Dis"},{"issue":"7","key":"R50-20260406","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"R51-20260406","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.21037\/jtd.2017.05.31","article-title":"South African Thoracic Society, Federation of Infectious Diseases Societies of Sothern Africa. South Africa guideline for the management of community-acquired pneumonia in adults","volume":"9","author":"Boyles","year":"2017","journal-title":"J Thorac Dis"},{"issue":"3","key":"R52-20260406","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/s11606-019-05508-3","article-title":"A comparison of AGREE and RIGHT: which clinical practice guideline reporting checklist should be followed by guideline developers?","volume":"35","author":"Yao","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"8","key":"R53-20260406","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/ptj\/pzaa075","article-title":"Methodological quality of physical therapy guidelines and their suitability for adaptation: a scoping review","volume":"100","author":"Becker","year":"2020","journal-title":"Phys Ther"},{"issue":"8","key":"R54-20260406","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1111\/jocn.17116","article-title":"Tracheostomy care of non-ventilated patients and COVID considerations: a scoping review of clinical practice guidelines and consensus statements","volume":"33","author":"Mu","year":"2024","journal-title":"J Clin Nurs"},{"issue":"76","key":"R55-20260406","first-page":"1","article-title":"Characteristic and quality of clinical practice guidelines for depression in adults: a scoping review","volume":"19","author":"Zafra-Tanaka","year":"2019","journal-title":"BMC Psychiatry"},{"issue":"6","key":"R56-20260406","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/bmjebm-2018-111153","article-title":"Evaluation of the NCCN guidelines using the RIGHT Statement and AGREE-II instrument: a cross-sectional review","volume":"24","author":"Wayant","year":"2019","journal-title":"BMJ J Evid Based Med"},{"key":"R57-20260406","doi-asserted-by":"crossref","first-page":"1260610","DOI":"10.3389\/fneur.2023.1260610","article-title":"Clinical practice guidelines for the diagnosis and management of Duchenne muscular dystrophy: a scoping review","volume":"14","author":"Malaga","year":"2024","journal-title":"Front Neurol"}],"container-title":["JBI Evidence Synthesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.11124\/JBIES-24-00565","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T12:50:48Z","timestamp":1786452648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.11124\/JBIES-24-00565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.11124\/jbies-24-00565","relation":{},"ISSN":["2689-8381"],"issn-type":[{"value":"2689-8381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]}}}